CRH (CRH) Given “Buy” Rating at UBS Group

Share on StockTwits

UBS Group restated their buy rating on shares of CRH (LON:CRH) in a report published on Thursday morning, Borsen Zeitung reports. They currently have a GBX 2,800 ($36.59) target price on the stock, up from their previous target price of GBX 2,700 ($35.28).

Separately, Numis Securities lowered CRH to a hold rating and set a GBX 2,685 ($35.08) price target on the stock. in a research report on Thursday, April 25th. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Buy and an average price target of GBX 2,904.50 ($37.95).

LON:CRH opened at GBX 2,491 ($32.55) on Thursday. The company has a market cap of $20.91 billion and a price-to-earnings ratio of 6.02. CRH has a twelve month low of GBX 1,961 ($25.62) and a twelve month high of GBX 2,891 ($37.78). The company has a current ratio of 1.57, a quick ratio of 0.97 and a debt-to-equity ratio of 56.63.

The business also recently declared a dividend, which was paid on Tuesday, April 30th. Shareholders of record on Thursday, March 14th were given a dividend of €0.52 ($0.61) per share. This is a positive change from CRH’s previous dividend of $0.20. The ex-dividend date of this dividend was Thursday, March 14th. This represents a dividend yield of 1.9%. CRH’s payout ratio is 0.15%.

CRH Company Profile

CRH plc, through its subsidiaries, manufactures and distributes building materials. It operates through three segments: Europe Materials, Americas Materials, and Building Products. The company manufactures and supplies cement, lime, aggregates, readymixed and precast concrete, and asphalt products; and construction accessories, architectural products, shutters and awnings, and perimeter protection and network access products.

Featured Story: Risk Tolerance

Analyst Recommendations for CRH (LON:CRH)

Receive News & Ratings for CRH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Harrow Health  Rating Increased to Buy at ValuEngine
Harrow Health Rating Increased to Buy at ValuEngine
NXP Semiconductors  Lifted to “Hold” at ValuEngine
NXP Semiconductors Lifted to “Hold” at ValuEngine
Blueprint Medicines Corp  Director Sells $1,124,482.70 in Stock
Blueprint Medicines Corp Director Sells $1,124,482.70 in Stock
Keith A. Meister Acquires 81,249 Shares of MGM Resorts International  Stock
Keith A. Meister Acquires 81,249 Shares of MGM Resorts International Stock
ITV  Stock Rating Reaffirmed by Macquarie
ITV Stock Rating Reaffirmed by Macquarie
Reviewing Silicon Motion Technology  and CEVA
Reviewing Silicon Motion Technology and CEVA


 
© 2006-2019 Zolmax.